Demars Financial Group LLC Has $122.44 Million Holdings in CME Group Inc. (NASDAQ:CME)

Demars Financial Group LLC grew its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 24,582.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 527,213 shares of the financial services provider's stock after acquiring an additional 525,077 shares during the period. CME Group comprises approximately 0.4% of Demars Financial Group LLC's portfolio, making the stock its 29th largest position. Demars Financial Group LLC owned 0.15% of CME Group worth $122,435,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Lake Street Advisors Group LLC increased its stake in CME Group by 108.7% in the fourth quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider's stock valued at $2,949,000 after purchasing an additional 6,453 shares during the period. Meyer Handelman Co. acquired a new stake in CME Group in the 4th quarter valued at about $6,144,000. Unified Investment Management acquired a new stake in CME Group during the 4th quarter valued at $503,000. Spire Wealth Management boosted its stake in shares of CME Group by 37.4% during the fourth quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider's stock valued at $307,000 after acquiring an additional 359 shares during the last quarter. Finally, AEGON ASSET MANAGEMENT UK Plc grew its stake in CME Group by 19.3% in the 4th quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider's stock worth $75,730,000 after acquiring an additional 52,862 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, COO Suzanne Sprague sold 1,500 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the sale, the chief operating officer now directly owns 8,036 shares in the company, valued at approximately $2,063,885.88. This trade represents a 15.73 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Julie Winkler sold 11,592 shares of the company's stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the transaction, the insider now owns 21,885 shares in the company, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,076 shares of company stock worth $6,871,496 over the last 90 days. 0.30% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages recently commented on CME. Bank of America upped their price target on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Erste Group Bank upgraded shares of CME Group to a "strong-buy" rating in a research note on Monday, March 17th. Barclays raised their price objective on CME Group from $263.00 to $279.00 and gave the company an "equal weight" rating in a research note on Monday, April 7th. Royal Bank of Canada reissued a "sector perform" rating and issued a $269.00 target price on shares of CME Group in a research report on Thursday, April 3rd. Finally, Piper Sandler upped their price target on CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a research report on Tuesday, April 8th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $247.47.

CME Group Price Performance

Shares of CME Group stock traded down $3.12 on Monday, hitting $259.41. The company had a trading volume of 1,399,577 shares, compared to its average volume of 2,142,537. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $273.42. The company has a market cap of $93.48 billion, a PE ratio of 26.83, a PEG ratio of 6.76 and a beta of 0.43. The business has a 50-day simple moving average of $257.19 and a 200-day simple moving average of $240.65. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Research analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were paid a $1.25 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a yield of 1.93%. This is a boost from CME Group's previous quarterly dividend of $1.15. CME Group's dividend payout ratio (DPR) is currently 51.71%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.